Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alteogen

Alteogen
2008 FOUNDED
PUBLIC STATUS
61-70 EMPLOYEES
196170 STOCK SYMBOL
$67.30 SHARE PRICE (As of Monday Closing)
Description

Alteogen Inc Inc is engaged in the development and manufacture of next-generation biopharmaceuticals using NexP Fusion Technology. It also develops & markets biobetters and biosimilars by partnerships with pharmaceutical companies. It focuses on the areas such as biobetters, a proprietary antibody-drug conjugate, and antibody biosimilars with complexity.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
KRX
Primary Office
  • Room 305 Daejeon-BioVenture Town)
  • 1662 Yuseong-daero, Yuseong-gu
  • Daejeon, 305-811
  • South Korea

+82 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alteogen’s full profile, request a free trial.

Alteogen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$16.78 - $86.73 $899M $65.48 -$0.05 731K 13.7M

Alteogen Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
31-Dec-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Enterprise Value 742,993 742,993 278,542 232,769
Revenue 25,066 25,066 12,467 10,674
EBITDA (1,230) (1,230) (5,730) (6,587)
Net Income (604) (604) (6,253) (6,569)
Total Assets 74,226 74,226 63,829 40,252
Total Debt 3,659 3,659 1,610 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alteogen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alteogen‘s full profile, request access.

Request full access to PitchBook

Alteogen Executive Team (2)

Name Title Board
Seat
Contact
Info
Soon Jae Park Chief Executive Officer
Hye-Shin Chung Ph.D Chief Technology Officer